248 related articles for article (PubMed ID: 11784784)
1. Differential inhibition of T-type calcium channels by neuroleptics.
Santi CM; Cayabyab FS; Sutton KG; McRory JE; Mezeyova J; Hamming KS; Parker D; Stea A; Snutch TP
J Neurosci; 2002 Jan; 22(2):396-403. PubMed ID: 11784784
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the Ca2 + currents induced by expression of three cloned alpha1 subunits, alpha1G, alpha1H and alpha1I, of low-voltage-activated T-type Ca2 + channels.
Klöckner U; Lee JH; Cribbs LL; Daud A; Hescheler J; Pereverzev A; Perez-Reyes E; Schneider T
Eur J Neurosci; 1999 Dec; 11(12):4171-8. PubMed ID: 10594642
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of recombinant Ca(v)3.1 (alpha(1G)) T-type calcium channels by the antipsychotic drug clozapine.
Choi KH; Rhim H
Eur J Pharmacol; 2010 Jan; 626(2-3):123-30. PubMed ID: 19782679
[TBL] [Abstract][Full Text] [Related]
4. Adrenal fasciculata cells express T-type and rapidly and slowly activating L-type Ca2+ channels that regulate cortisol secretion.
Enyeart JJ; Enyeart JA
Am J Physiol Cell Physiol; 2015 Jun; 308(11):C899-918. PubMed ID: 25788571
[TBL] [Abstract][Full Text] [Related]
5. Nickel block of three cloned T-type calcium channels: low concentrations selectively block alpha1H.
Lee JH; Gomora JC; Cribbs LL; Perez-Reyes E
Biophys J; 1999 Dec; 77(6):3034-42. PubMed ID: 10585925
[TBL] [Abstract][Full Text] [Related]
6. Dual pharmacological properties of a cyclic AMP-sensitive potassium channel.
Gomora JC; Enyeart JJ
J Pharmacol Exp Ther; 1999 Jul; 290(1):266-75. PubMed ID: 10381786
[TBL] [Abstract][Full Text] [Related]
7. In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice.
Kraus RL; Li Y; Gregan Y; Gotter AL; Uebele VN; Fox SV; Doran SM; Barrow JC; Yang ZQ; Reger TS; Koblan KS; Renger JJ
J Pharmacol Exp Ther; 2010 Nov; 335(2):409-17. PubMed ID: 20682849
[TBL] [Abstract][Full Text] [Related]
8. Preferential block of T-type calcium channels by neuroleptics in neural crest-derived rat and human C cell lines.
Enyeart JJ; Biagi BA; Mlinar B
Mol Pharmacol; 1992 Aug; 42(2):364-72. PubMed ID: 1355264
[TBL] [Abstract][Full Text] [Related]
9. Kurtoxin, a gating modifier of neuronal high- and low-threshold ca channels.
Sidach SS; Mintz IM
J Neurosci; 2002 Mar; 22(6):2023-34. PubMed ID: 11896142
[TBL] [Abstract][Full Text] [Related]
10. Neuroleptic drugs attenuate calcium influx and tension development in rabbit thoracic aorta: effects of pimozide, penfluridol, chlorpromazine, and haloperidol.
Flaim SF; Brannan MD; Swigart SC; Gleason MM; Muschek LD
Proc Natl Acad Sci U S A; 1985 Feb; 82(4):1237-41. PubMed ID: 2579392
[TBL] [Abstract][Full Text] [Related]
11. Antischizophrenic drugs of the diphenylbutylpiperidine type act as calcium channel antagonists.
Gould RJ; Murphy KM; Reynolds IJ; Snyder SH
Proc Natl Acad Sci U S A; 1983 Aug; 80(16):5122-5. PubMed ID: 6136040
[TBL] [Abstract][Full Text] [Related]
12. Identification of T-type alpha1H Ca2+ channels (Ca(v)3.2) in major pelvic ganglion neurons.
Lee JH; Kim EG; Park BG; Kim KH; Cha SK; Kong ID; Lee JW; Jeong SW
J Neurophysiol; 2002 Jun; 87(6):2844-50. PubMed ID: 12037187
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology of recombinant low-voltage activated calcium channels.
Lacinová L
Curr Drug Targets CNS Neurol Disord; 2004 Apr; 3(2):105-11. PubMed ID: 15078185
[TBL] [Abstract][Full Text] [Related]
14. T-type Ca(2+) channel modulation by otilonium bromide.
Strege PR; Sha L; Beyder A; Bernard CE; Perez-Reyes E; Evangelista S; Gibbons SJ; Szurszewski JH; Farrugia G
Am J Physiol Gastrointest Liver Physiol; 2010 May; 298(5):G706-13. PubMed ID: 20203058
[TBL] [Abstract][Full Text] [Related]
15. State-dependent verapamil block of the cloned human Ca(v)3.1 T-type Ca(2+) channel.
Freeze BS; McNulty MM; Hanck DA
Mol Pharmacol; 2006 Aug; 70(2):718-26. PubMed ID: 16699084
[TBL] [Abstract][Full Text] [Related]
16. Mibefradil block of cloned T-type calcium channels.
Martin RL; Lee JH; Cribbs LL; Perez-Reyes E; Hanck DA
J Pharmacol Exp Ther; 2000 Oct; 295(1):302-8. PubMed ID: 10991994
[TBL] [Abstract][Full Text] [Related]
17. Distinct kinetics of cloned T-type Ca2 + channels lead to differential Ca2 + entry and frequency-dependence during mock action potentials.
Kozlov AS; McKenna F; Lee JH; Cribbs LL; Perez-Reyes E; Feltz A; Lambert RC
Eur J Neurosci; 1999 Dec; 11(12):4149-58. PubMed ID: 10594640
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological properties of Ca(V)3.2, a low voltage-activated Ca2+ channel cloned from human heart.
Perchenet L; Bénardeau A; Ertel EA
Naunyn Schmiedebergs Arch Pharmacol; 2000 Jun; 361(6):590-9. PubMed ID: 10882033
[TBL] [Abstract][Full Text] [Related]
19. Generation and characterization of a cell line with inducible expression of Ca(v)3.2 (T-type) channels.
Xia M; Imredy JP; Santarelli VP; Liang HA; Condra CL; Bennett P; Koblan KS; Connolly TM
Assay Drug Dev Technol; 2003 Oct; 1(5):637-45. PubMed ID: 15090236
[TBL] [Abstract][Full Text] [Related]
20. Roscovitine inhibits CaV3.1 (T-type) channels by preferentially affecting closed-state inactivation.
Yarotskyy V; Elmslie KS
J Pharmacol Exp Ther; 2012 Feb; 340(2):463-72. PubMed ID: 22088954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
